Physician profile

Erik Wayne

Vascular Surgery · Louisville, KY

NPI 1295907277

$25,031.80

in general payments reported to CMS, 2019-2025

28 companies · $5,194 in 2025

The $5,194 reported for 2025 was more than what 85% of Vascular Surgery providers received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,215.97
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$1,200.00
Travel and Lodging$919.57
Education$50.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $10,339.85 2019-2025 Indigo System, Penumbra System
Boston Scientific Corporation $4,033.71 2019-2025 Ekosonic, Eluvia, General - Atherectomy
Abbott Laboratories $2,351.00 2019-2025 Esprit, Jeti Peripheral Catheter, Diamondback Peripheral
W. L. Gore & Associates, INC. $1,465.13 2021-2025 Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, C3 Delivery System
Silk Road Medical, INC. $1,433.50 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Cook Medical LLC $1,369.94 2019-2025 Zenith, Zilver Ptx, Zenith Spiral-Z
Bolton Medical INC $1,192.52 2025 Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System
Ekos Corporation $836.66 2019
Endologix LLC $492.57 2019-2024 Endocross Device, Torus Stent Graft System
Cardiovascular Systems INC. $352.66 2019-2022
Stryker Corporation $197.75 2025 Limflow System
Smith+Nephew, INC. $171.36 2024 Pico 14, Pico 7, Renasys Touch
Sanara Medtech INC. $168.37 2025 Celleraterx
Terumo Medical Corporation $102.91 2022-2024 Glidewire, Azur Cx Detachable, Metacross Otw
Bard Peripheral Vascular, INC. $100.07 2022-2025 Pristine, Venovo, Denali Vena Cava Filter
Show all 28 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $88.18 2019-2023 Camzyos
Medtronic, INC. $53.17 2022-2024 Endurant Iis
Allergan, INC. $50.96 2019
Cerus Corporation $39.83 2023 Intercept Blood System For Platelets
Inari Medical, INC. $38.50 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Baxter Healthcare $34.71 2022
Getinge USA Sales, LLC $29.63 2022
Atricure, INC. $25.81 2025 Atricure Cryoice Cryosphere Cryoablation System
Philips North America LLC $15.87 2022
Dilon Technologies, INC. $14.67 2023 Hemoblast Bellows
Elutia, INC. $12.49 2020
Pfizer INC. $10.96 2019
Kerecis Limited $9.02 2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Erik Wayne

$25,031.80

in general payments reported 2019-2025

Years
2019-2025
Top company
Penumbra, INC.
Context
The $5,194 reported for 2025 was more than what 85% of Vascular Surgery providers received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/1366948/erik-wayne

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.